Goldman Sachs’s Genomic Health, Inc. GHDX Stock Holding History

Goldman Sachs’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-40,000	Closed	-$846K	–	7481
2015 Q3	$846K	Buy	40,000 +3,000	+8%	+$77.3K	﹤0.01%	4640
2015 Q2	$1.03M	Sell	37,000 -13,000	-26%	-$367K	﹤0.01%	4522
2015 Q1	$1.53M	Buy	50,000 +45,400	+987%	+$1.44M	﹤0.01%	4041
2014 Q4	$147K	Sell	4,600 -85,900	-95%	-$2.8M	﹤0.01%	6372
2014 Q3	$2.56M	Buy	+90,500	New	+$2.52M	﹤0.01%	3688
2013 Q3	–	Sell	-50,000	Closed	-$1.59M	–	6775
2013 Q2	$1.59M	Buy	+50,000	New	+$1.64M	﹤0.01%	3948

Goldman Sachs's GHDX Position: Q4 2019 in Review

Goldman Sachs sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 265,344 shares — an estimated $18M sold.

Goldman Sachs first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $54.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Goldman Sachs reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Goldman Sachs sold 265,344 Genomic Health, Inc. shares in Q4 2019, an estimated $18M.
Goldman Sachs first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
Goldman Sachs's Genomic Health, Inc. position peaked at $54.6M in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.